MedTrace Logo

Professional Impact of Osteoarticular Trauma

NCT07419217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2026-08-25

No results posted yet for this study

Summary

This study aims to describe the medical, social, and organizational determinants of returning to work after an osteoarticular injury, particularly limb fractures.

Using observational data, the study will evaluate the modalities of returning to work within 12 months of the injury and analyze the factors influencing professional reintegration, including the severity of the injury, functional recovery, pain, professional characteristics, workplace accommodations, and administrative support measures such as recognition of disabled worker status.

The study will also explore the point at which the issue of returning to work is first raised with the patient during hospitalization, a period during which professional reintegration is often insufficiently anticipated. By identifying current practices and breaking points, this study aims to improve understanding of the pathways to returning to work in the context of the healthcare system and the world of work in France.

Conditions

  • Rehabilitation
  • Return to Work
  • Occupational Health/Medicine
  • Work Capacity Evaluation
  • Disabled Persons
  • Vocational Rehabilitation

Sponsors & Collaborators

  • Hopitaux de Saint-Maurice

    lead OTHER

Principal Investigators

  • Belot BS Sylvain, PH · Hôpitaux Paris Est Val-de-Marne, service de rééducation et réadaptation des affections du système locomoteur adulte,Saint-Maurice 94410

  • Meriem MA Ait Mamar, MD · Hôpitaux Paris Est Val-de-Marne, service de rééducation et réadaptation des affections du système locomoteur adulte, Saint-Maurice 94410

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-18
Primary Completion
2026-02-20
Completion
2026-03-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07419217 on ClinicalTrials.gov